Bio-Works signs distribution agreement with Yong Chien Technology Inc. in Taiwan
Bio-Works Technologies (Nasdaq First North) has signed a Distribution Agreement with Taipei-based Yong Chien Technology Inc. The agreement covers import, storage, distribution, marketing promotion and sales of WorkBeads resins and pre-packed BabyBio and OptioBio columns in Taiwan.
Bio-Works is strengthening its presence in Taiwan by engaging a well-respected local distributor with years of experience of supplying downstream bioprocessing solutions to academia, research institutes and the growing domestic biotech, biosimilar and biopharma industry.
Bio-Works cutting edge proprietary agarose resins, WorkBeads™ are well-suited not only for the purification of biological compounds for biopharmaceuticals, but also for peptides and proteins used by the cosmetic industry, industrial enzyme production, diagnostic kits and in vaccine manufacturing using various vectors and antigens, DNA and RNA. Bio-Works have a particularly strong portfolio in IMAC, probably offering the largest selections of chelating agents already supplied with metal counter ions for swift and easy use. Furthermore, WorkBeads IEX-resins are already used in USFDA and EMA approved peptide therapeutics offering unparallel cost savings in large scale manufacturing.
“Yong Chien Technology Inc and its partners offer far better coverage of Taiwan than we have previously had. We are encouraged by Mr Angus Wu’s network not only in the biotech industry but also into academia and research institutes, which would pave the way for better penetration of the Taiwanese market,” says Mr Jonathan Royce, Bio-Works’ CEO.
Yong Chien Technologies was established 13 years ago with the aim of bringing best-in-class life science products to laboratories and biotech companies in Taiwan from global suppliers. This in order to be able to serve efforts in genomics and proteomics R&D, separation and purification of biomolecules from lab to full production scale.
“We are very glad to sign this distribution agreement with Bio-Works enabling us to introduce Bio-Work’s high quality and cost-effective chromatography resins to our customers across Taiwan,” says Mr Angus Wu, Managing Director of Yong Chien Technology Inc.
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Jonathan Royce, CEO, e-mail: jonathan.royce@bio-works.com, phone: +46 70 1434143.
Bio-Works designs, develops, manufactures and supplies innovative leading-edge agarose products for chromatographic separation of proteins, peptides and other biomolecules. Bio-Works’ agarose based high performance products are used for purification in the life science research phases as well as the commercial production of biopharmaceuticals and diagnostic products in large scale. The products are sold globally with our own organization and via distributors. The Bio-Works’ headquarter with R&D and manufacturing is located in Uppsala Business Park in Uppsala, Sweden and the company processes and a Quality Management System follows the standards of ISO 9001:2015. The company’s share is listed on Nasdaq First North. FNCA Sweden AB, +46 (0) 8-528 00 399, info@fnca.se, is appointed Certified Adviser.